echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > BVT and BIOGARD signed a cooperation agreement to use the insecticide containing Beauveria bassiana ATCC 74040 strain in the bee drug delivery system

    BVT and BIOGARD signed a cooperation agreement to use the insecticide containing Beauveria bassiana ATCC 74040 strain in the bee drug delivery system

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    World agricultural nets Chinese news report: Bee Vectoring Technologies ( "Company" or "BVT") announced today Europe's leading bio- one protection agent company CBC (Europe) Srl's first commercial BIOGARD signed a cooperation agreement
    .
    BIOGARD containing Beauveria bassiana ATCC 74040 strain biological pesticides will be granted the drug is administered by the system BVT bees, the product will be in the EU sales and Switzerland
    .
    Michael Collinson, Chairman of BVT, said: "The first commercial agreement with partners from the European Union is an important step in the development of
    BVT.
    For BVT, this is the most important global milestone since it was registered by the U.
    S.
    Environmental Protection Agency in 2019.

    With this According to the agreement, BVT can conduct business in the EU by developing and registering approved products containing biologically active substances and applied by bees without waiting for the approval of new active substance submission materials, and this process may take 3 years
    The signing of this agreement also clearly shows that the industry has begun to realize the value of our efficient use of bee application systems in achieving crop protection
    .
    "According to the agreement, BVT will use BIOGARD's active substance registration to develop a biopesticide solution, which will be delivered to crops through BVT's proprietary honeybee drug platform
    .
    This solution can be superimposed with BVT's own biological fungicide Gliocladium roseum strain CR-7 (CR-7 for short) to provide a comprehensive sterilization and insecticidal solution for certain crops
    .
    If there is no target disease, the solution can also be used as an insecticide alone
    .
    Compared with the traditional application method, the active ingredient can be directly delivered to the flower of the crop with the help of bee application, without any waste, so that the product consumption per unit area of ​​the crop can be reduced by up to 98%
    .
    The agreement also includes a long-term arrangement for BIOGARD to provide active substances to BVT
    .
    Vittorio Veronelli, CEO of CBC (Europe) Srl, said: “BVT is a true innovator in the field of sustainable agricultural practices and natural pest control.

    BVT and BIOGARD have exactly the same goal of promoting sustainable agricultural practices.

    BIOGARD’s microbial pesticides use Bee application will give full play to its effect
    .
    This is a win-win result for the European market
    .
    "   BIOGARD has provided biological control products for 30 years
    .
    The company was formed by the merger of CBC (Europe) Srl and Intrachem Bio Italy and is a recognized leader in the industry
    .
    BIOGARD's microbial insecticide Beauveria bassiana ATCC 74040 has been registered in the European Union, and it has been used to control thrips, whiteflies and aphids through foliar spraying for 10 years
    .
    These pests cause damage to a variety of crops, including strawberries and peppers, and these crops are one of the priority target uses of the BVT solution
    .
       BVT CEO Ashish Malik said: "This agreement has achieved two important
    firsts of BVT.
    It promotes the entry of BVT into the European Union, enabling us to obtain the first revenue from this region, and in our efforts to complete CR- 7’s registration and approval process at the same time to prove our technology to growers
    .
    This is also our first product expansion by introducing third-party biological agents for BVT’s bee drug delivery system
    .
    This transaction proves that BVT’s technology can be used for delivery A variety of biological control agents have also extended our solutions beyond the field of disease control and entered the field of pest control
    .
    This is an exciting opportunity for BVT, allowing us to increase value for growers all over the world , To help them adopt more sustainable practices while also increasing BVT’s revenue
    .
    "   The European pesticide market value is estimated at US$2 billion
    .
    Due to the growing consumer demand for organic food and the increasing pressure from EU regulators to require farmers to adopt more sustainable agricultural practices, Europe has now become the world's second largest bioprotective agent market
    .
    The primary goal of BVT is the greenhouse production of crops such as strawberries and peppers.
    These crops are planted in Europe on an area of ​​about 500,000 acres, of which 100,000 acres are grown in greenhouses
    .
       The company's strategy includes three major elements: continued commercialization in the United States; global expansion; and expansion of the product portfolio
    .
    This cooperation is the first milestone in the strategy to expand the product portfolio
    .
    Biological insecticides EU   Michael Collinson, Chairman of BVT, said: "The first commercial agreement with partners from the European Union is an important step in the development of
    BVT.
    For BVT, this is the most important global milestone since it was registered by the U.
    S.
    Environmental Protection Agency in 2019.

    With this According to the agreement, BVT can conduct business in the EU by developing and registering approved products containing biologically active substances and applied by bees without waiting for the approval of new active substance submission materials, and this process may take 3 years
    The signing of this agreement also clearly shows that the industry has begun to realize the value of our efficient use of bee application systems in achieving crop protection
    .
    "   According to the agreement, BVT will use BIOGARD's active substance registration to develop a biopesticide solution, which will be delivered to crops through BVT's proprietary honeybee drug platform
    .
    This solution can be superimposed with BVT's own biological fungicide Gliocladium roseum strain CR-7 (CR-7 for short) to provide a comprehensive sterilization and insecticidal solution for certain crops
    .
    If there is no target disease, the solution can also be used as an insecticide alone
    .
    Compared with the traditional application method, the active ingredient can be directly delivered to the flower of the crop with the help of bee application, without any waste, so that the product consumption per unit area of ​​the crop can be reduced by up to 98%
    .
    The agreement also includes a long-term arrangement for BIOGARD to provide active substances to BVT
    .
       Vittorio Veronelli, CEO of CBC (Europe) Srl, said: “BVT is a true innovator in the field of sustainable agricultural practices and natural pest control.

    BVT and BIOGARD have exactly the same goal of promoting sustainable agricultural practices.

    BIOGARD’s microbial pesticides use Bee application will give full play to its effect
    .
    This is a win-win result for the European market
    .
    "   BIOGARD has provided biological control products for 30 years
    .
    The company was formed by the merger of CBC (Europe) Srl and Intrachem Bio Italy and is a recognized leader in the industry
    .
    BIOGARD's microbial insecticide Beauveria bassiana ATCC 74040 has been registered in the European Union, and it has been used to control thrips, whiteflies and aphids through foliar spraying for 10 years
    .
    These pests cause damage to a variety of crops, including strawberries and peppers, and these crops are one of the priority target uses of the BVT solution
    .
       BVT CEO Ashish Malik said: "This agreement has achieved two important
    firsts of BVT.
    It promotes the entry of BVT into the European Union, enabling us to obtain the first revenue from this region, and in our efforts to complete CR- 7’s registration and approval process at the same time to prove our technology to growers
    .
    This is also our first product expansion by introducing third-party biological agents for BVT’s bee drug delivery system
    .
    This transaction proves that BVT’s technology can be used for delivery A variety of biological control agents have also extended our solutions beyond the field of disease control and entered the field of pest control
    .
    This is an exciting opportunity for BVT, allowing us to increase value for growers all over the world , To help them adopt more sustainable practices while also increasing BVT’s revenue
    .
    "   The European pesticide market value is estimated at US$2 billion
    .
    Due to the growing consumer demand for organic food and the increasing pressure from EU regulators to require farmers to adopt more sustainable agricultural practices, Europe has now become the world's second largest bioprotective agent market
    .
    The primary goal of BVT is the greenhouse production of crops such as strawberries and peppers.
    These crops are planted in Europe on an area of ​​about 500,000 acres, of which 100,000 acres are grown in greenhouses
    .
       The company's strategy includes three major elements: continued commercialization in the United States; global expansion; and expansion of the product portfolio
    .
    This cooperation is the first milestone in the strategy to expand the product portfolio
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.